Tumor angiogenesis and anti‑angiogenic gene therapy for cancer

T Li, G Kang, T Wang, HE Huang - Oncology letters, 2018 - spandidos-publications.com
When Folkman first suggested a theory about the association between angiogenesis and
tumor growth in 1971, the hypothesis of targeting angiogenesis to treat cancer was formed …

Gene electrotransfer: a mechanistic perspective

C Rosazza, S Haberl Meglic, A Zumbusch… - Current gene …, 2016 - ingentaconnect.com
Gene electrotransfer is a powerful method of DNA delivery offering several medical
applications, among the most promising of which are DNA vaccination and gene therapy for …

Genetically edited T-cell membrane coated AIEgen nanoparticles effectively prevents glioblastoma recurrence

W Wang, F Wu, M Mohammadniaei, M Zhang, Y Li… - Biomaterials, 2023 - Elsevier
Glioblastoma stem cells (GSCs) are subpopulations of tumor-initiating cells responsible for
glioblastoma (GBM) tumorigenesis and recurrence. Dual inhibition of vascular endothelium …

Recent advances of nanotechnology-based tumor vessel-targeting strategies

D Zhu, Y Li, Z Zhang, Z Xue, Z Hua, X Luo… - Journal of …, 2021 - Springer
Tumor vessels can provide oxygen and nutrition for solid tumor tissue, create abnormal
tumor microenvironment (TME), and play a vital role in the development, immune escape …

Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting

B Layek, T Sadhukha, J Panyam, S Prabha - Molecular Cancer Therapeutics, 2018 - AACR
Tumor-targeted drug delivery has the potential to improve therapeutic efficacy and mitigate
non-specific toxicity of anticancer drugs. However, current drug delivery approaches rely on …

Nano-engineered mesenchymal stem cells as targeted therapeutic carriers

T Sadhukha, TD O'Brien, S Prabha - Journal of controlled Release, 2014 - Elsevier
Poor availability in deep-seated solid tumors is a significant challenge that limits the
effectiveness of currently used anticancer drugs. Approaches that can specifically enhance …

Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration

R Waters, S Pacelli, R Maloney, I Medhi, RPH Ahmed… - Nanoscale, 2016 - pubs.rsc.org
A nanocomposite hydrogel with photocrosslinkable micro-porous networks and a nanoclay
component was successfully prepared to control the release of growth factor-rich stem cell …

Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour

SJ Tseng, ZX Liao, SH Kao, YF Zeng, KY Huang… - Nature …, 2015 - nature.com
Anticancer therapies are often compromised by nonspecific effects and challenged by
tumour environments' inherent physicochemical and biological characteristics. Often …

Chitosan nanoparticles for nuclear targeting: the effect of nanoparticle size and nuclear localization sequence density

SN Tammam, HME Azzazy, HG Breitinger… - Molecular …, 2015 - ACS Publications
Many recently discovered therapeutic proteins exert their main function in the nucleus, thus
requiring both efficient uptake and correct intracellular targeting. Chitosan nanoparticles …

[HTML][HTML] Tumor progression-dependent angiogenesis in gastric cancer and its potential application

HL Hsieh, MM Tsai - World journal of gastrointestinal oncology, 2019 - ncbi.nlm.nih.gov
Despite improvements in the early diagnosis, prognosis and therapeutic strategies for
gastric cancer (GC), human GC remains one of the most frequently diagnosed malignant …